Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Erick Crespo-Solís"'
Autor:
Álvaro Cabrera-García, Lauro Fabián Amador-Medina, Roberta Demichelis-Gómez, David Gómez-Almaguer, Karla Espinosa-Bautista, Juan Carlos Solís-Poblano, Ramiro Espinoza, Lilia Adela García-Stivalet, Efreen Horacio Montaño-Figueroa, Carolina Moreira, Nidia Zapata-Canto, Erick Crespo-Solís, Etta Rozen-Fuller, Alva Zaragoza, Ramón Alejandro Martínez-Hernández, Ruth Gutiérrez-Serdán, Carolina García-Castillo, Angel Carrillo, Faustino Leyto-Cruz, Alejandro Limon, Francisco Turrubiates, Eduardo Terreros-Muñoz, Luis Meillon, Perla R. Colunga-Pedraza, Elia Ixel Apodaca, Guillermo Diaz-Vargas
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(6)
Background In the past decades, long-term survival outcomes for younger patients with acute myeloid leukemia (AML) have improved. Nonetheless, developing nations might be lagging behind, highlighting the need to assess real-world outcomes in such reg
Autor:
Fernando Pérez-Jacobo, Erick Crespo-Solís, Alvaro Aguayo, Elena Tuna-Aguilar, Xavier López-Karpovitch, Roberta Demichelis-Gómez, Ubaldo Rafael Valencia-Rocha
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:778-784
Data from 51 patients (23 women) with chronic myeloid leukemia (CML) in blast phase (BP) were analyzed in order to identify prognostic factors for complete hematologic response (CHR) and survival.Forty-four patients experienced disease progression fr
Autor:
Héctor Zamarripa-Gutiérrez, Erick Crespo-Solís, Sylvia González-Esparza, Óscar del Ángel-Guevara, Juan Jesús Maldonado-Muñoz, Ramón Alejandro Martínez-Hernández
Publikováno v:
Revista Hospital Medicine and Clinical Management. 11
Publikováno v:
Current Oncology Reports. 14:369-378
Cerebrospinal fluid-acute leukemia (CSF-acute leukemia) is a frequent and serious complication in patients with acute leukemia. One of the major problems of this complication is the diagnosis process itself. CSF cytology is currently considered the g
Autor:
Roberta, Demichelis-Gómez, Erick, Crespo-Solís, Luis Fernando, Pérez-Jacobo, Ubaldo Rafael, Valencia-Rocha, Adriana, Rosas-López
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 67(5)
Treatment of relapsed/refractory acute myeloid or lymphoid leukemia consists of salvage chemotherapy followed by allogeneic hematopoietic stem-cell transplantation. Intravenous fludarabine, cytarabine, and filgrastim is an effective regimen in this s
Autor:
Lauro Fabián, Amador-Medina, Dennis, Lacayo-Leñero, Erick, Crespo-Solís, Álvaro, Aguayo, Déborah, Martínez-Baños
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 67(5)
Novel therapies for multiple myeloma are not affordable for all healthcare systems.The objectives of this study were to evaluate the response rates, overall survival, event-free survival, and toxicity of thalidomide and dexamethasone administered unt
Autor:
Gabriela Anaya-Saavedra, Imelda González-Ramírez, Esther Irigoyen Camacho, Sergio Ponce-de-León, Velia Ramírez-Amador, Erick Crespo-Solís
Publikováno v:
Supportive Care in Cancer. 18:639-646
Knowledge of oral mucositis (OM) in patients with acute leukemia (AL) and chemotherapy (CT) has remained limited. Thus, a prospective, longitudinal study was undertaken to characterize clinical features, associated risk factors, and behavior of OM in
Autor:
Yael Cazares-Ordonez, Elizabeth Guadarrama-Beltran, Erick Crespo-Solís, Alvaro Aguayo, Xavier López-Karpovitch, Eduardo E. Cervera-Ceballos, Eunice Garcia-Alvarez, Deborah Martinez-Baños
Publikováno v:
Clinical Leukemia. 2:261-266
Background: Chronic myeloid leukemia (CML) is a malignant disease caused by the protein coded by the Philadelphia chromosome. Imatinib mesylate (IM) is now the treatment of choice for all stages of CML. Clinicoepidemiologic information on CML from de
Publikováno v:
Archives of Medical Research. 39:541-545
High P-glycoprotein-mediated multidrug resistance-1 (P-gp/MDR1) activity in lymphocytes from idiopathic thrombocytopenic purpura (ITP) patients may affect disease outcome. ITP treatment includes glucocorticoids that are substrates of P-gp; hence, P-g
Autor:
Sergio Rodríguez-Rodríguez, Christian Omar Ramos-Peñafiel, Fernando Perez-Rocha, Chantal Nava-Gomez, Roberta Demichelis-Gómez, Alan Pomerantz-Okon, Erick Crespo-Solís, José Luis Álvarez-Vera, Luis Antonio Meillón-García, Etta Rozen-Fuller, Karla Espinosa-Bautista, Martha Alvarado-Ibarra, Maricela Ortiz-Zepeda
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:S252